195 related articles for article (PubMed ID: 34646338)
1. Identification of the Molecular Subgroups in Idiopathic Pulmonary Fibrosis by Gene Expression Profiles.
Zhang N; Guo Y; Wu C; Jiang B; Wang Y
Comput Math Methods Med; 2021; 2021():7922594. PubMed ID: 34646338
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the underlying mechanisms of Sanleng-Ezhu for the treatment of idiopathic pulmonary fibrosis based on network pharmacology and single-cell RNA sequencing data.
Zhou X; Tan F; Zhang S; Zhang T
Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37559532
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis.
Liu Y; Xu C; Gao W; Liu H; Li C; Chen M
Genet Res (Camb); 2022; 2022():7448481. PubMed ID: 35919036
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis.
Cecchini MJ; Hosein K; Howlett CJ; Joseph M; Mura M
Respir Res; 2018 Aug; 19(1):153. PubMed ID: 30111332
[TBL] [Abstract][Full Text] [Related]
5. Weighted Gene Coexpression Network Analysis Identifies Key Genes and Pathways Associated with Idiopathic Pulmonary Fibrosis.
Wang Z; Zhu J; Chen F; Ma L
Med Sci Monit; 2019 Jun; 25():4285-4304. PubMed ID: 31177264
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid metabolism-related genes in bronchoalveolar lavage fluid unveil prognostic and immune infiltration in idiopathic pulmonary fibrosis.
Lyu Y; Guo C; Zhang H
Front Endocrinol (Lausanne); 2022; 13():1001563. PubMed ID: 36267568
[TBL] [Abstract][Full Text] [Related]
7. Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis.
Wang E; Wang Y; Zhou S; Xia X; Han R; Fei G; Zeng D; Wang R
Int J Med Sci; 2022; 19(9):1417-1429. PubMed ID: 36035368
[No Abstract] [Full Text] [Related]
8. The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and
Zeng L; Tang Y; Zhang Y; Yue L; Ma G; Ye X; Yang L; Chen K; Zhou Q
Front Immunol; 2023; 14():1288098. PubMed ID: 37928522
[TBL] [Abstract][Full Text] [Related]
9. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
10. Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
Wang Y; Yella JK; Ghandikota S; Cherukuri TC; Ediga HH; Madala SK; Jegga AG
Ther Adv Respir Dis; 2020; 14():1753466620971143. PubMed ID: 33167785
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a bronchoalveolar lavage cell-associated gene signature for prognosis prediction in idiopathic pulmonary fibrosis.
Xia Y; Lei C; Yang D; Luo H
Int Immunopharmacol; 2021 Mar; 92():107369. PubMed ID: 33493738
[TBL] [Abstract][Full Text] [Related]
12. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
Leng D; Yi J; Xiang M; Zhao H; Zhang Y
BMC Cancer; 2020 Oct; 20(1):986. PubMed ID: 33046043
[TBL] [Abstract][Full Text] [Related]
13. A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.
Huang Y; Ma SF; Vij R; Oldham JM; Herazo-Maya J; Broderick SM; Strek ME; White SR; Hogarth DK; Sandbo NK; Lussier YA; Gibson KF; Kaminski N; Garcia JG; Noth I
BMC Pulm Med; 2015 Nov; 15():147. PubMed ID: 26589497
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.
Kim SK; Jung SM; Park KS; Kim KJ
BMC Pulm Med; 2021 Dec; 21(1):404. PubMed ID: 34876074
[TBL] [Abstract][Full Text] [Related]
15. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis.
Yang IV; Coldren CD; Leach SM; Seibold MA; Murphy E; Lin J; Rosen R; Neidermyer AJ; McKean DF; Groshong SD; Cool C; Cosgrove GP; Lynch DA; Brown KK; Schwarz MI; Fingerlin TE; Schwartz DA
Thorax; 2013 Dec; 68(12):1114-21. PubMed ID: 23783374
[TBL] [Abstract][Full Text] [Related]
16. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
Wang Y; Yella J; Chen J; McCormack FX; Madala SK; Jegga AG
BMC Pulm Med; 2017 Oct; 17(1):133. PubMed ID: 29058630
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis of next‑generation sequencing data to identify dysregulated genes in fibroblasts of idiopathic pulmonary fibrosis.
Sheu CC; Chang WA; Tsai MJ; Liao SH; Chong IW; Kuo PL
Int J Mol Med; 2019 Apr; 43(4):1643-1656. PubMed ID: 30720061
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomics in idiopathic pulmonary fibrosis unveiled: a new perspective from differentially expressed genes to therapeutic targets.
Hu W; Xu Y
Front Immunol; 2024; 15():1375171. PubMed ID: 38566986
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape.
Wang Y; Chen S; Chen S; Jiang J
J Cell Mol Med; 2024 Jun; 28(11):e18414. PubMed ID: 38872435
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular subgroups in osteomyelitis induced by staphylococcus aureus infection through gene expression profiles.
Shi X; Ni H; Tang L; Li M; Wu Y; Xu Y
BMC Med Genomics; 2023 Jun; 16(1):149. PubMed ID: 37370094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
